Treatment of adult patients with relapsed or refractory follicular lymphoma (FL) after two or more lines of systemic therapy
For the treatment of adult patients with relapsed or refractory (r/r) diffuse large B cell lymphoma (DLBCL) after two or more lines of systemic therapy.
Treatment of paediatric and young adult patients up to 25 years with B-cell acute lymphoblastic leukaemia (ALL) that is refractory, in relapse post-transplant or in second or later relapse
No medicines have been found.
